Postprandial Hyperglycemia: Clinical Trials

2 trials for Postprandial Hyperglycemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 2

Follow Postprandial Hyperglycemia: new trials by email Literature Review of Postprandial Hyperglycemia trials Research Report on Postprandial Hyperglycemia

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Acarbose on Postprandial Lipoprotein Levels in Glucose Intolerant Patients
Acarbose, Placebo - Glucose Intolerance, Postprandial Hyperglycemia
Phase 4CompletedInstituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran212010-01-012015-02-09
Effects of Insulin Treatment on Postprandial Platelet Activation in Patients With Non-insulin-dependent Diabetes Mellitus (NIDDM)
Insulin aspart (Novorapid®) - Type 2 Diabetes Mellitus, Postprandial Hyperglycemia
Phase 4CompletedKarolinska Institutet182007-05-012022-05-27

Narrower conditions

Hyperglycemia (2)  ·  Diabetes Mellitus, Type 2 (1)  ·  Glucose Intolerance (1)  ·  Insulin Resistance (1)

Broader conditions

Glucose Metabolism Disorders (2)  ·  Metabolic Diseases (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Diabetes Mellitus (1)  ·  Endocrine System Diseases (1)  ·  Hyperinsulinism (1)

Interventions

Acarbose (1)  ·  Insulin Aspart (1)

Sponsors

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran (1)  ·  Karolinska Institutet (1)

Countries

Mexico (1)  ·  Sweden (1)

Top investigators

Paul Hjemdahl, MD, PhD (1)

Results publications

PMID 22688337